Sustained healthcare systems need sustainable pharma business modelsCOVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing. Share XSustained healthcare systems need sustainable pharma business modelshttps://pharmaphorum.com/sales-marketing/healthcare-systems-pharma-business-models/
EU panel rejects Pfizer’s tanezumab for osteoarthritis painAny lingering hope that Pfizer may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor Share XEU panel rejects Pfizer’s tanezumab for osteoarthritis painhttps://pharmaphorum.com/news/eu-panel-rejects-pfizers-tanezumab-for-osteoarthritis-pain/
Teva faces EU antitrust probe over MS drug CopaxoneThe European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company Share XTeva faces EU antitrust probe over MS drug Copaxonehttps://pharmaphorum.com/news/teva-faces-eu-antitrust-probe-over-ms-drug-copaxone/
EU fines Teva and Cephalon €60.5m for ‘pay for delay’ schemeThe European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for Share XEU fines Teva and Cephalon €60.5m for ‘pay for delay’ schemehttps://pharmaphorum.com/news/eu-fines-teva-and-cephalon-e60-5m-for-pay-for-delay-scheme/
NICE backs Lilly’s Emgality for migraine, adding pressure on NovartisUK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the NHS for Share XNICE backs Lilly’s Emgality for migraine, adding pressure on Novartishttps://pharmaphorum.com/news/nice-backs-lillys-emgality-for-migraine-adding-pressure-on-novartis-rival/
Gilead pays $97m to resolve US illegal kickback claimsGilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a Share XGilead pays $97m to resolve US illegal kickback claimshttps://pharmaphorum.com/news/gilead-pays-97m-to-resolve-us-illegal-kickback-claims/
Teva charged in US price-fixing investigationThe US Department of Justice has charged Teva with conspiring with other pharma companies to fix prices for Share XTeva charged in US price-fixing investigationhttps://pharmaphorum.com/news/teva-charged-in-us-price-fixing-investigation/
Teva shares slide as it faces illegal kickback charges from US governmentShares in Teva were down sharply this week after the US Department of Justice filed a complaint that Share XTeva shares slide as it faces illegal kickback charges from US governmenthttps://pharmaphorum.com/news/teva-shares-slide-as-it-faces-illegal-kickback-charges-from-us-government/
Teva launches digital asthma and COPD rescue inhaler in USTeva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to Share XTeva launches digital asthma and COPD rescue inhaler in UShttps://pharmaphorum.com/news/fda-approves-tevas-digital-asthma-and-copd-rescue-inhaler/
